MAPT and Alzheimer disease: The hyperphosphorylation of Tau is widely considered a pathological hallmark of AD, with about 85 putative phosphorylation sites (p-sites) having been predicted (Ser, Thr, and Tyr) along the amino acid sequence of Tau; however, not all the p-sites are disease-associated or toxic [25,26].